Core Viewpoint - The stock of Kangtong Medical (301515) has shown a decline in both price and net inflow of funds, indicating potential challenges in market sentiment and financial performance [1][2]. Financial Performance - As of January 28, 2026, Kangtong Medical's stock closed at 24.11 yuan, down 1.27% with a trading volume of 17,500 hands and a transaction amount of 42.43 million yuan [1]. - The company reported a net profit of -10.21 million yuan for the first three quarters of 2025, a year-on-year decrease of 150.92% [3]. - The gross profit margin stands at 22.45%, significantly lower than the industry average of 50.94% [3]. Fund Flow Analysis - On January 28, 2026, the main funds experienced a net outflow of 1.58 million yuan, accounting for 3.73% of the total transaction amount, while retail investors saw a net inflow of 4.83 million yuan, representing 11.38% of the total [1][2]. - Over the past five days, the stock has seen a consistent trend of net outflows from main and speculative funds, with retail investors being the only group showing net inflows [2]. Industry Comparison - Kangtong Medical's total market capitalization is 2.41 billion yuan, which is significantly lower than the industry average of 11.21 billion yuan [3]. - The company's price-to-earnings ratio (P/E) is -177.13, indicating negative earnings, while the industry average is 104.86 [3]. - The company ranks 120th in total market value and 99th in net assets within the medical device industry [3].
股票行情快报：港通医疗（301515）1月28日主力资金净卖出158.40万元